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256 Pathophysiology o f  acute coronary syndromes
Multiple pre-conditioning stimuli attenuate 
protection against the infarct size in rabbits
E.K. Iliodromitis, C. Papadopoulos, D. Katritsis, Z.S. Kyriakides, E. Bofilis,
D.T. Kremastinos. 2nd Dept, of Cardiology, Onassis Cardiac Surgery Center, 
Athens, Greece
The aim of the study was to determine if the repeated periods of 5 min ischemia 
and 10 min reperfusion (5 isc/10 rep) are protective against the infarct size in 
a collateral deficient modef.
Methods: Forty-one rabbits were divided into 7 groups. Group (Gp) A (n = 5) 
was subjected to one cycle of 5 isc/10 rep, GpB (n =  5) was subjected to two 
5 isc/10 rep, GpC (n = 7) to four 5 isc/10 rep, GpD (n =  7) to six 5 isc/10 rep, 
GpE (n as 7) and GpF (n =  5) to eight 5 isc/10 rep while GpG (n = 5) served as 
control. After the initial interventions all the Gps (except GpF) were subjected 
to 45 min regional ischemia and 2 hours reperfusion. The elapsed time from 
the first preconditioning stimulus to the final 45 min ischemic insult was 15, 30, 
60, 90 and 120 mins, respectively for the Gps A, B, C , D and E. infarct size
(i) and risk zones (R) were delineated with the aid of tetrazolium staining and 
fluorescent particles* l/R ratio was expressed in percent (% l/R).
Groups A B C D E F G
2.2 ±2.5* 19.5±4.1* 23.3 ±3.4* 41.8 ±  6.9#t 47.1 ±7.6*
O-H0 59.8 ± 4
*p < 0.001 vs G, < 0.05 vs A, B, C, tp  < 0.05 vs G
Conclusion: These results indicate that protection against infarct size dimin 
ishes after multiple and repetitive preconditioning stimuli in rabbits.
Reperfusion damage is mediated by a stable 
long-lasting cardiac metabolite which is probably not 
a protein
V. Stangl, S.B. Felix, T. Frank, O. Rôdiger, T. Berndt, G. Baumann. 
Medizinische Klinik I, Charité, Humboldt-Universitat Berlin, Germany
We have previously reported that after giobal ischemia (IS) of an isolated heart 
cardi ode pressant agents are released during reperfusion (R) which induced 
a pronounced but reversible decrease In contractility in a serially perfused non 
ischemic second heart (H2) (double heart model)* This effect was not attributable 
to changes in pH or concentration of electrolytes of the coronary effluent and the 
metabolites do probably not derive from coronary endothelium. In order to further 
characterize the chemical structure of these mediators w e investigated whether 
storage of the coronary effluent for several hours or days, heating to 56°C for 30 
min or protease treatment influence the negative inotropic effect 
Two isolated guinea pig hearts were perfused separately at constant flow (10 
ml/min) with a modified Krebs-Henseleit-soIution oxygenated with 95% O2 and 
5%  C 0 2. This was followed by serial perfusion without {group 1, n = 5) and 
with {group 2, n = 5) preceding IS (10 min) of the first heart (H1). In group 1 
no significant changes of the left ventricular contractile parameters of H2 were 
observed during serial perfusion. In group 2, after a global 10-min IS of H1 
left ventricular (LV) systolic pressure of H2 (basal 76*3 ± 3 . 5  mmHg, SEM) 
immediately decreased by 16%, +LVdP/dtmax (1491.9 ±  112.4 mmHg/s by 22%, 
-UVdP/dtmax (1261.3 ±  56.8 mmHg/s) by 30% when R  was started. Coronary 
perfusion pressure (77.1 ±  3.4 cmH20 )  decreased by 26% . These parameters 
returned to baseline within 10 min. Heart rate did not change significantly. The 
cardiodepressant effect of the coronary effluent was not destroyed by protease 
treatment (chymotrypsine 0.005 U) or by heating the coronary effluent to 56°C  
for 30 min. Coronary effluent kept at room temperature for 24 hours before 
delivery to H2 also retained its activity.
These data suggest the release of a stable, long-lasting cardiodepressant 
agent from myocardial tissue after global IS during R. The resistance against 
protease treatment and heating suggests that the mediator is not a protein.
Production of interleukin-6 triggers an enhanced 
acute phase response after percutaneous coronary 
angioplasty in patients with unstable angina
G. Liuzzo, A. Buffon, A. Vitelli1, G. Ciliberto1, G. Callgiurl, G. Quaranta,
C. Monaco, F. Crea, L.M. Biasucci, A, Maseri. UCSC; 1 IRBMRome, Italy
C-reactive protein (CRP) levels are predictors of prognosis in unstable angina 
(UA) and increase further after coronary angioplasty (PTCA). As interleukin-6 
(IL-6) is the major inducer of the acute phase proteins production, we have 
measured IL-6 and CRP levels in 32 UA pts, undergoing single-vessel PTCA. 
Venous blood samples were taken immediately before PTCA and 6-24-48-72 
h after the end of the procedure. Results (median and range): Before PTCA, 
elevated levels of CRP (> 3  mg/l) were observed in 23 /32  pts (72%, G1) and 
normal levels in 9/23 pts (28%, G2). Detectable levels of IL-6 (undetectable in 
normals) were found in 13/23 (57%) G1 pts, but in none G2 pts. After PTCA, 
in G1 pts CRP levels increased from 9.8 (3.2-29) mg/l to a peak value of 21 
(4.4—174) mg/l 24 h after the end of the procedure (p <  0.001 vs baseline). 
This increase was preceded by a significant increase of IL-6 at 6 h [from 2
(0-22) pg/ml to 6.2 (0-300) pg/ml, p = 0.002]. IL-6 remained high at 24 h (6.8 
(3-148) pg/ml; p = 0.32 vs 6 h] and then returned to the baseline value by 48 
h [2.5 (0-47) pg/ml; p = 0.97 vs baseline]. Conversely, CRP levels remained 
elevated at 48 h and decreased to baseline at 72 h, consistently with the 
plasma half life of CRP compared to that of IL-6. No changes in CRP and IL-6 
levels were observed in G2 pts. There was a significant correlation between 
the peak values of IL-6 and CRP (r = 0.53, p = 0.01). The figure shows the 
median values of IL-6 (circles) and CRP (squares), in G1 pts. Conclusion: UA 
pts with elevated levels of CRP exhibit an enhanced production of IL-6 early 
after PTCA, followed by a large increase of CRP. In turn, IL-6 production may 
be triggered by powerful pro-inflammatory stimuli contained in the plaque core 
or may reflect a lower threshold for IL-6 synthesis in this subset of UA pts.
C-Reactive protein co-localizes with complement in 
human hearts during acute myocardial infarction
W.K. Lag rand1, J.W.M. Nlessen2, G.J. Wolbink4, E.H. Jaspars2,
C.A. Visser1, F.W.A. Verheugt1, C.J.L.M. Meijer2, C.E. Hack3,4. 1 Free 
University Hospital, Department of Cardiology;2 Department of Pathology;
3 Department of internal Medicine; 4 Central Laboratory of the Netherlands 
Red Cross Blood Transfusion Service, Amsterdam, The Netherlands
Plasma levels of C-reactlve protein (CRP) correlate with clinical outcome in 
patients with myocardial ischemia and infarction. We hypothesized that these 
correlations might reflect active participation of CRP in the local inflammatory 
response ensueing in the jeopardized myocardium, since upon binding to a 
ligand CRP is able to activate the classical pathway of complement. In addition, 
complement activation has been shown to occur locally in human infarcted 
myocardium. To verify our hypothesis, we investigated immunohlstochemicaS 
localization of CRP, in relation to deposition of complement, in tissue specimens 
of infarcted and normal heart tissues obtained from 17 patients, who had died 
following acute myocardial infarction (AMI). CRP was found to be deposited only 
In infarcted regions and not in normal appearing areas of human myocardium, 
being co*localized with depositions of C4- and C3-actlvation fragments of 
the complement system. Deposition of CRP and complement in infarcted 
myocardium appeared to be time-dependent since it was found in all infarctions 
except for one of very short duration ( < 12 hours) and two of long duration ( > 
1 year). Thus, CRP may localize in infarcted human heart tissue. W e  suggest 
that this acute phase protein promotes local complement activation, and hence 
tissue damage in AMI,
Assessment of C-reactive protein levels after 
percutaneous transluminal coronary angioplasty and 
stent implantation
F. Versaci, F. Tomai, A. Gaspardone, A. De Fazio, M. lamele, F. Benvissulo,
F. Crea, P.A. Gioffrè. Divisione di Cardiochirurgia, Università Tor Vergata, 
Rome, Italy
In patients (pts) with acute coronary syndromes increased serum levels ol 
C-reactive protein (CRP) are associated to a worse short-term outcome. The 
aim of this study was to establish whether coronary angioplasty (PTCA) or 
stent implantation (SI) have the potential to increase serum levels of CRP 
and whether the latter affects the short and long term prognosis. Ninety-nine 
pts (mean age 58 ± 7 years, 88 men) with stable angina and obstructive 
coronary atherosclerosis were randomised to PTCA (49 pts) or to SI (50 pts). 
There were no significant differences among the two groups with respect to 
baseline clinical characteristics (gender, previous myocardial infarctions, risk 
factors and therapy) and to angiographic characteristics before the procedures. 
Serum CRP levels were measured, by nephelometry, 24 hours before and 6 
hours, 1 day, 2 days, 3 days and 4 days after the procedure. All pts were then 
followed-up for 6 months. Serum levels of CRP were obtained also at 3 and 6 
months. Serum levels of CRP (mg/L) were as follows (mean ± SD values):
PTCA S) P
Baseline 2.1 ±0.6 2.0 ±0 .6 NS
6-hours 3.9 ±3.6 3.9 ±  3,5 NS
1-day 4.6 ±5.2 8.7 ±  6.8* NS
2-days 8.2 ±10* 21 ±18* p =  0.002
3-days 4.4 ±  5.0 10.8 ±16* p — 0.02
3-months 2.0 ±0.7 2.4 ±1.3 NS
6-months 2.7 ±1.5 2.3 ±1.0 NS
*p < 0.05 vs baseline value
The incidence of early complications and symptoms recurrence was similar 
after PTCA and SI (2 vs 2%, p = NS and 10 vs 16%, p = NS, respectively).
Conclusions: SI results in a much higher increase of CRP serum levels 
than that observed after PTCA; yet, the incidence of early complications and 
late outcomes is similar. Thus, a marked elevation of CRP caused by an 
inflammatory stimulus localized in an epicardial coronary vessel is not sufficient 
per se to trigger coronary instability.
